Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus-Reference-Cited by-同舟云学术

Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus

Published:2023-08-07 Issue: Volume: Page:
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

D’Amico Ferdinando¹²^ORCID,Magro Fernando³,Siegmund Britta⁴^ORCID,Kobayashi Taku⁵,Kotze Paulo Gustavo⁶,Solitano Virginia²⁷,Caron Benedicte⁸⁹,Al Awadhi Sameer¹⁰,Hart Ailsa¹¹,Jairath Vipul⁷,Dignass Axel¹²,Peyrin-Biroulet Laurent⁸⁹,Danese Silvio¹^ORCID

Affiliation:

1. Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University , Milan , Italy

2. Department of Biomedical Sciences, Humanitas University , Pieve Emanuele, Milan , Italy

3. Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine of the University of Porto , Porto , Portugal

4. Medizinische Klinik m. S. Gastroenterologie, Infektiologie und Rheumatologie, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin , Berlin , Germany

5. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo , Japan

6. Colorectal Surgery Unit, Hospital Universitário Cajuru, Pontifícia Universidade Católica do Paraná (PUCPR) , Curitiba , Brazil

7. Department of Medicine, Division of Gastroenterology, Western University , London, Ontario , Canada

8. University of Lorraine, CHRU-Nancy, Department of Gastroenterology , F-54000 Nancy , France

9. University of Lorraine, Inserm, NGERE , F-54000 Nancy , France

10. Digestive Diseases Unit, Rashid Hospital , Dubai 003206 , United Arab Emirates

11. St Mark’s Hospital , Harrow , Middlesex , UK

12. Department of Medicine I, Agaplesion Markus Hospital, Goethe-University , Frankfurt am Main , Germany

Abstract

AbstractThe concept of disease clearance has been proposed as a potential target in ulcerative colitis (UC). We conducted a systematic review to investigate the role of disease clearance, defined as a composite outcome including simultaneous clinical, endoscopic, and histologic remission of disease in the management of patients with UC. Based on the literature data, statements regarding disease clearance were developed and voted on by the members of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) according to a Delphi methodology. A definition of disease clearance was proposed to standardize its use in clinical practice and clinical trials and to provide practical recommendations for its implementation as a therapeutic target in UC.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izad159/51048408/izad159.pdf

Reference59 articles.

1. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol.,2015

2. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD;Turner;Gastroenterology.,2021

3. A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis;Arias;Clin Gastroenterol Hepatol.,2015

4. Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC;Colombel;Gut.,2017

5. Histologic remission: the ultimate therapeutic goal in ulcerative colitis;Peyrin-Biroulet;Clin Gastroenterol Hepatol.,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep mucosal healing in ulcerative colitis: how deep is better?;Frontiers in Medicine;2024-08-02

2. Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With Etrasimod;Clinical Gastroenterology and Hepatology;2024-07

3. Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection;European Journal of Pediatrics;2024-05-06

4. Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey;Journal of Clinical Medicine;2024-04-24

5. Disease clearance in ulcerative colitis: A new therapeutic target for the future;World Journal of Gastroenterology;2024-04-07